FDA import refusals
FDA import refusals: dietary supplements from Norway
FDA category: Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties · October 2016 to April 18, 2025
FDA refused 7 dietary supplements shipment lines from Norway between October 2016 and April 18, 2025, 2 of them in 2025; the most refused products were vitamin and fats and lipid substances, most often for NUTRIT LBL (nutrition information missing from label).
Data from FDA public records, last checked .
- 7
- dietary supplements lines refused since October 2016
- 2
- refused so far in 2025
- 0
- firms with the most records, listed below
Dietary supplements refusals from Norway by year
Shipment lines FDA refused each year. The table has the same numbers as the chart.
| Year | Refusal lines | vs prior year |
|---|---|---|
| 2025 | 2 | |
| 2023 | 1 | |
| 2020 | 1 | |
| 2018 | 1 | -50% |
| 2017 | 2 |
Vitamin refusals from Norway
FDA refused 4 vitamin lines from Norway between October 2016 and April 18, 2025, 57% of the dietary supplements lines.
| FDA product description | Lines | Share of dietary supplements |
|---|---|---|
| Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. | 4 | 57.1% |
Recent vitamin refusals
| Date | Firm | Product | Charges | |
|---|---|---|---|---|
| Hofseth Biocare AsaAlesund, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LABELINGNUTRIT LBL | Source | |
| Hofseth Biocare AsaAlesund, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LABELINGNUTRIT LBL | Source | |
| Faun Pharma ASVestby, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | NO ENGLISH | Source | |
| Orkla Health ASOslo, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LIST INGREDIETARYINGNCONTACT+2 | Source |
Fats and lipid substances refusals from Norway
FDA refused 2 fats and lipid substances lines from Norway between October 2016 and April 18, 2025, 29% of the dietary supplements lines.
| FDA product description | Lines | Share of dietary supplements |
|---|---|---|
| Fats and lipid substances, n.e.c. | 2 | 28.6% |
Recent fats and lipid substances refusals
| Date | Firm | Product | Charges | |
|---|---|---|---|---|
| Vistin Pharma ASKragero, Norway | Fats and lipid substances, n.e.c | UNAPPROVED | Source | |
| Vistin Pharma ASKragero, Norway | Fats and lipid substances, n.e.c | UNAPPROVED | Source |
Protein n.e.c. refusals from Norway
FDA refused 1 protein n.e.c. line from Norway between October 2016 and April 18, 2025, 14% of the dietary supplements lines.
| FDA product description | Lines | Share of dietary supplements |
|---|---|---|
| Protein n.e.c. | 1 | 14.3% |
Recent protein n.e.c. refusals
| Date | Firm | Product | Charges | |
|---|---|---|---|---|
| Pharmatech ASRolvsoy, Norway | Protein n.e.c | INCONSPICUNUTRIT LBL | Source |
Why FDA refused dietary supplements from Norway
FDA records a charge code on each refused line; one line can carry several.
| Charge code | Meaning | Lines | Share |
|---|---|---|---|
| NUTRIT LBL | Nutrition information missing from label | 4 | 29% |
| LABELING | Fair Packaging and Labeling Act | 3 | 21% |
| UNAPPROVED | Unapproved new drug | 2 | 14% |
| DIETARYING | Dietary ingredients not listed | 1 | 7% |
| INCONSPICU | Required information not conspicuous | 1 | 7% |
| LIST INGRE | Ingredients not listed | 1 | 7% |
| NCONTACT | No U.S. adverse event contact on supplement label | 1 | 7% |
| NO ENGLISH | Required label information not in English | 1 | 7% |
Latest dietary supplements refusals from Norway
| Date | Firm | Product | Charges | |
|---|---|---|---|---|
| Hofseth Biocare AsaAlesund, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LABELINGNUTRIT LBL | Source | |
| Hofseth Biocare AsaAlesund, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LABELINGNUTRIT LBL | Source | |
| Faun Pharma ASVestby, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | NO ENGLISH | Source | |
| Orkla Health ASOslo, Norway | Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c | LIST INGREDIETARYINGNCONTACT+2 | Source | |
| Pharmatech ASRolvsoy, Norway | Protein n.e.c | INCONSPICUNUTRIT LBL | Source | |
| Vistin Pharma ASKragero, Norway | Fats and lipid substances, n.e.c | UNAPPROVED | Source | |
| Vistin Pharma ASKragero, Norway | Fats and lipid substances, n.e.c | UNAPPROVED | Source |
Questions about dietary supplements refusals from Norway
- How many dietary supplements shipments from Norway did FDA refuse in 2025?
- FDA refused 2 shipment lines of dietary supplements from Norway in 2025 through April 18, 2025.
- Why does FDA refuse dietary supplements from Norway?
- FDA records a charge code on every refused shipment line. For dietary supplements from Norway the most frequent are NUTRIT LBL (nutrition information missing from label, 4 lines), LABELING (Fair Packaging and Labeling Act, 3 lines) and UNAPPROVED (unapproved new drug, 2 lines). A charge describes what FDA's reference table says about one shipment line, not about every firm.
- Which import alerts cover dietary supplements from Norway?
- As of October 26, 2026, no import alert numbered under this category lists a firm in Norway in SupplierRadar's records. General food alerts numbered 99-xx can still list Norway firms; see the country page.
Built for the person who signs the FSVP file
Buying dietary supplements from Norway?
Check each Norway supplier against every FDA record in one paste, free for five suppliers. Watch the ones you buy from and get the source the day a record changes.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.